SGCE Promotes Breast Cancer Stemness by Promoting the Transcription of FGF-BP1 by Sp1

Researchers found that ε-Sarcoglycan (SGCE) depletion reduces breast cancer stem cells, partially through inhibiting the transcription of FGF-BP1, a secreted oncoprotein.